Stock 600812 NORTH CHINA PHARMACEUTICAL COMPANY.LTD
Add to a list
To use this feature you must be a member
Log inSign up

Highlights North China Pharmaceutical Company.Ltd

Equities

600812

CNE000000D16

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-05-21 pm EDT 		5-day change 1st Jan Change
5.07 CNY -0.78% Intraday chart for North China Pharmaceutical Company.Ltd -2.31% -11.05%
May. 17 North China Pharmaceutical Unit Gets China Nod for Rabies Vaccine MT
Apr. 25 North China Pharmaceutical Company.Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
North China Pharmaceutical Company.Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
North China Pharmaceutical Company.Ltd agreed to acquire the remaining 35.85% stake in NCPC Hebei Huamin Pharmaceutical Co., Ltd. from CCB Financial Asset Investment Co., Ltd. for CNY 670 million
CI
North China Pharmaceutical Company.Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
CI
North China Pharmaceutical Subsidiary Gets Europe's Compliance Certification for Drug Raw Material
MT
North China Pharmaceutical Company.Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
North China Pharmaceutical Company.Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
CI
North China Pharmaceutical Company Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
North China Pharmaceutical's Heart Drug Passes Regulatory Evaluation
MT
North China Pharmaceutical Company Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
North China Pharmaceutical Company Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
North China Pharmaceutical Company Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
China Rolls Out New Rules to Fight Monopoly in API Drugmaking Market
MT
North China Pharmaceutical Company Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
CI
North China Pharmaceutical Company Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
CI
Chinese vitamin C price-fixing lawsuit thrown out by U.S. appeals court
RE
North China Pharmaceutical Company Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
North China Pharmaceutical Company. Ltd completed the acquisition of North China Pharmaceutical Group Corporation Veterinary Co., Ltd., from North China Pharmaceutical Group Corp.
CI
Jizhong Energy Resources Co., Ltd. completed the acquisition of a 10% stake in North China Pharmaceutical Company. Ltd from Jizhong Energy Group Company Limited.
CI
North China Pharmaceutical Company. Ltd Reports Earnings Results for the Nine Months Ended September 30, 2020
CI
Jizhong Energy Resources Co., Ltd. signed an agreement to acquire a 10% stake in North China Pharmaceutical Company. Ltd from Jizhong Energy Group Company Limited for CNY 2.2 billion.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 600812 Stock
  4. News North China Pharmaceutical Company.Ltd
  5. Highlights